|
    AB France: Euronext Paris

    AB Science S.A.

    ABFR
    Closed
    Back To Top
    Last Updated: Jul 26, 2021 5:35 p.m. CEDT Delayed quote

    15.05

    -0.26 -1.70%
    Previous Close
    €15.31
    Advanced Charting
    • $
    • %
    • Vol
    Volume: 165.91K 65 Day Avg: 351.75K
    47% vs Avg
    14.81 Day Range 15.58
    6.95 52 Week Range 21.75

    Your Watchlists

    Customize eLesor

    Have Watchlists? Log in to see them here or sign up to get started.

    Symbol
    Company
    Price
    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    AB Overview

    Performance

    5 Day
    • 7.73%
    1 Month
    • 85.69%
    3 Month
    • -5.46%
    YTD
    • -23.45%
    1 Year
    • 75.61%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 1 Full Ratings

    Recent News

    • eLesor
    • Dow Jones

    No Headlines Available

    • Other News
    • Press Releases

    No Headlines Available

    AB Science S.A.

    AB Science SA engages in the research, development, and sales of protein kinase inhibitor drugs. It develops pharmaceutical products for the treatment of cancer, neurological, and inflammatory diseases. The firm also engages in the field of veterinary medicine. The company was founded by Alain Moussy and Jean-Pierre Kinet on July 11, 2001 and is headquartered in Paris, France.

    Competitors

    Name Chg % Market Cap
    Genfit S.A. -1.93% €151.86M
    IntegraGen S.A. -3.14% €10.6M
    Virbac S.A. -0.15% €2.79B
    Nanobiotix -0.50% €414.62M
    Hybrigenics S.A. -0.81% €51.99M
    Neovacs S.A. 2.78% €12.82M
    Quantum Genomics S.A.S. 3.91%
    Qiagen N.V. -0.79% €10.1B
    Vetoquinol 0.39% €1.23B
    Competitor Data Provided ByCapital Cube Logo